Improved method of treating degenerative spinal disorders

Details for Australian Patent Application No. 2006261357 (hide)

Owner Abbott Laboratories

Inventors Hooper, David; Hunt, Margaret M.; Meunier, Alain; Jara-Alamonte, James

Agent Spruson & Ferguson

Pub. Number AU-A-2006261357

PCT Pub. Number WO2006/138690

Priority 60/691,711 17.06.05 US

Filing date 19 June 2006

Wipo publication date 28 December 2006

International Classifications

A61F 2/44 (2006.01) Filters - for the spine, e.g. vertebrae, spinal discs

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

1 November 2007 PCT application entered the National Phase

  PCT publication WO2006/138690 Priority application(s): WO2006/138690

22 October 2009 Alteration of Name

  The name of the applicant has been altered to Zimmer Spine Austin, Inc.

19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006261358-Topical vasoconstrictor preparations and methods for protecting cells during cancer chemotherapy and radiotherapy

2006261356-Improved amino acid and metabolite biosynthesis